Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 213.60B P/E 37.80 EPS this Y 0.80% Ern Qtrly Grth 13.70%
Income 6.22B Forward P/E 22.40 EPS next Y 9.70% 50D Avg Chg 5.00%
Sales 42.35B PEG 4.09 EPS past 5Y 9.92% 200D Avg Chg 2.00%
Dividend N/A Price/Book 4.88 EPS next 5Y 6.90% 52W High Chg -9.00%
Recommedations 2.00 Quick Ratio 1.24 Shares Outstanding 382M 52W Low Chg 16.00%
Insider Own 0.18% ROA 4.83% Shares Float 381.14M Beta 0.78
Inst Own 90.95% ROE 13.53% Shares Shorted/Prior 3.99M/3.32M Price 553.76
Gross Margin 40.69% Profit Margin 14.69% Avg. Volume 1,704,174 Target Price 653.16
Oper. Margin 17.40% Earnings Date Oct 23 Volume 1,398,652 Change 1.45%
About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific Inc News
11/20/24 End Market Growth, New Acquisitions Drive Thermo Fisher's Shares
11/19/24 The Zacks Analyst Blog Highlights Thermo Fisher Scientific, NextEra Energy and Lowe's
11/18/24 Top Analyst Reports for Thermo Fisher, NextEra Energy & Lowe's
11/18/24 Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
11/15/24 Thermo Fisher's $4 Billion Buyback: A Game-Changer for Investors
11/15/24 Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
11/15/24 Thermo Fisher eliminating 160 jobs, closing Massachusetts facility
11/14/24 Thermo Fisher Scientific's (NYSE:TMO) five-year total shareholder returns outpace the underlying earnings growth
11/12/24 Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
11/11/24 Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024
11/09/24 Thermo Fisher Scientific Inc. (TMO): Among the Best Low Volatility Stocks to Invest In Now
11/09/24 Is Weakness In Thermo Fisher Scientific Inc. (NYSE:TMO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
11/07/24 Thermo Fisher Scientific Declares Quarterly Dividend
11/07/24 Thermo Fisher Scientific (TMO) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates Era
11/04/24 Why Thermo Fisher (TMO) International Revenue Trends Deserve Your Attention
11/04/24 Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 30% Below Their Intrinsic Value Estimate
11/04/24 Aristotle Atlantic Focus Growth Strategy Liquidated Thermo Fisher Scientific (TMO)
11/02/24 Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT Insight
10/31/24 Thermo Fisher Scientific Insiders Sold US$2.3m Of Shares Suggesting Hesitancy
10/31/24 Devyser Diagnostics AB (FRA:OL0) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges
TMO Chatroom

User Image silentfury Posted - 14 hours ago

$MYNZ this will up hard. $TMO running hard after hours. I feel this partnership will be epic. Just got to have patience.

User Image AileenColeman Posted - 16 hours ago

$TMO bought 30M shares of $MYNZ? can someone explain the offering deal ? If it is this is huge 🤑 will be $5 in short term

User Image Allie_Vo Posted - 19 hours ago

$MYNZ check this out, comparison on CRC tests in US (who’s the leader???): Mainz Biomed costs $200 (88% detection) $GH Guardant Health costs $1,495 (20% detection) $EXAS Exact Sciences costs $500 (42% detection) Colonoscopy: $2,750 The average cost of a colonoscopy is $2,750, but the total can range from $1,250 to $4,800, depending on where you live, where you have the procedure performed and what your insurance covers (if you have insurance) $TMO partnership gonna change everything.

User Image AlessandroMartin Posted - 19 hours ago

$XCUR $MYNZ $TMO i believe in you!!!!!

User Image AlexisBryan__ Posted - 19 hours ago

$MYNZ can you imagine how Mainz with $TMO gonna reflect on this? It’s $10 per share stock in very short term $GME

User Image NalaniNavarro Posted - 20 hours ago

$MYNZ no way this stock not fly like $DRUG after $TMO partnership

User Image EliannaButler__ Posted - 20 hours ago

$MYNZ + $TMO huge partnership, for sure it will go up soon

User Image StrayTrader Posted - 23 hours ago

$TMO surprised this doesn’t bounce at least $20

User Image lextrading Posted - 1 day ago

$TMO At support.

User Image Juhanialainen Posted - 1 day ago

$MYNZ The offering is closed, no more dilution. I hope they’ll soon tell us who bought the direct offering. 🤞for $TMO. Fools selling now, when it’s about to reverse big time.

User Image swingingtech Posted - 1 day ago

$TMO https://wallstreetwaves.com/thermo-fisher-scientific-stock-analysis-what-are-analysts-saying/

User Image CasperPuff Posted - 1 day ago

$TMO

User Image AryanGH Posted - 1 day ago

$TMO Hopefully 500 will be the bottom on this.

User Image Shinigamy Posted - 1 day ago

$TMO reversal today

User Image Cammmmmmmm Posted - 1 day ago

$TMO we will be green today.

User Image tradingtwenty Posted - 1 day ago

Top 5 oversold stocks that have trended in the past 24 hours: $JNPR 11.03🔥 $ASC 15.16 $CATX 16.59 $TMO 18.40 $BIIB 19.02 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image cubie Posted - 2 days ago

@jenbunn @judgeyoung2 @Alvi722 @lowfloatscambuster @EBE_Day @Ollip @ribbey @TraderRapp @tonyctl @lukenight $biib $BMRN 52 week lows today, $UTHR $tmo $regn more pharma and bio related stonks that pullbacked lot recently

User Image 100Financial Posted - 2 days ago

$TMO No one can time the market with 100% accuracy but we go by our technical and algo analysis. No emotions involved. Why to jump on FOMO when its not ready yet.

User Image 100Financial Posted - 2 days ago

$TMO To all followers, this is a free tip. We are eyeing on TMO like a hawk. Its almost there but Not yet close to the PT. Will alert members as son as it hits.

User Image Cammmmmmmm Posted - 2 days ago

$TMO I think we’re at the bottom, then every time I check it’s even lower. Good grief

User Image scalpdaddy57 Posted - 2 days ago

$TMO good risk reward for a long

User Image RBaggio25 Posted - 2 days ago

$TMO someone somewhere, please make this pain stop

User Image billybilnaadd Posted - 2 days ago

$TMO this is ridiculous. Time to buy the dip.

User Image TacoMan81 Posted - 2 days ago

$TMO $MYNZ hmmmm 👀

User Image StrayTrader Posted - 2 days ago

$TMO also shockingly bad

User Image StrayTrader Posted - 2 days ago

$TMO Jesus, use the buyback already

User Image grancougar Posted - 2 days ago

$DRUG $MYNZ $TMO

User Image NGCS Posted - 2 days ago

$MYNZ To summarize: 1. there would be (but not confirmed) an R/S but not before foreseeably 180 days (unless it exceeds 1 dollar before, but with news about TMO financing, maybe not to compliance NASDAQ); 2. They must report the conditions of $TMO ´s financing/collaboration/participation in the project (if satisfactory, the share price may skyrocket to 2 - 5 USD without R/s); 3. The R/S percentage should be known to also comply with the minimum number of shares (5 million) for the NASDAQ (for example, if it were 1:50, then shares would have to be diluted to reach the minimum of 5 million shares from the current 1.2 million); 4. Advances in the marketing of the drug thanks to TMO and other commercial channels; 5. Other issues such as volume of shorts, etc. If everything goes well (better than expected) it could happen like with $DRUG . It's just my personal opinion, but I think that if TMO financing conditions are good enough, no R/S would happen.

User Image JD222 Posted - 2 days ago

$MYNZ If $TMO funded the best efforts offering, I believe we will know by Friday. Have a great week, everyone.

User Image RBaggio25 Posted - 2 days ago

$TMO the never ending pain continues

Analyst Ratings
Evercore ISI Group Outperform Oct 1, 24
Stephens & Co. Overweight Oct 1, 24
JP Morgan Overweight Sep 20, 24
Stifel Buy Sep 20, 24
RBC Capital Outperform Sep 20, 24
Morgan Stanley Overweight Sep 20, 24
B of A Securities Buy Sep 16, 24
Wells Fargo Overweight Aug 27, 24
TD Cowen Buy Jul 25, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Pettiti Gianluca Executive Vice Presi.. Executive Vice President Aug 30 Sell 557.77 3,000 1,673,310 17,556 08/31/23
Pettiti Gianluca Executive Vice Presi.. Executive Vice President Aug 30 Option 253.99 3,000 761,970 20,556 08/31/23
CASPER MARC N Chairman & CEO Chairman & CEO May 08 Sell 541.28 11,600 6,278,848 141,330 05/10/23
CASPER MARC N Chairman & CEO Chairman & CEO May 08 Option 157.68 11,600 1,829,088 142,930 05/10/23
Pettiti Gianluca Executive Vice Presi.. Executive Vice President Dec 13 Option 210.68 4,975 1,048,133 21,425 12/15/22
Pettiti Gianluca Executive Vice Presi.. Executive Vice President Dec 13 Sell 572.98 6,975 3,996,536 14,450 12/15/22
CASPER MARC N Chairman & CEO Chairman & CEO Nov 04 Option 129.77 18,100 2,348,837 186,105 11/08/22
CASPER MARC N Chairman & CEO Chairman & CEO Nov 04 Sell 491.78 18,100 8,901,218 178,005 11/08/22
CASPER MARC N Chairman & CEO Chairman & CEO Oct 31 Option 129.77 20,000 2,595,400 188,005 11/02/22
CASPER MARC N Chairman & CEO Chairman & CEO Oct 31 Sell 514.66 20,000 10,293,200 178,005 11/02/22
Williamson Stephen Sr. VP and CFO Sr. VP and CFO Aug 12 Option 157.68 27,300 4,304,664 56,244 08/16/22
Williamson Stephen Sr. VP and CFO Sr. VP and CFO Aug 12 Sell 602.98 27,300 16,461,354 43,944 08/16/22
Boxer Michael A SVP and General Coun.. SVP and General Counsel Aug 08 Option 192.98 7,283 1,405,473 19,681 08/10/22
Boxer Michael A SVP and General Coun.. SVP and General Counsel Aug 08 Sell 590.8 7,283 4,302,796 12,398 08/10/22
Lagarde Michel Executive Vice Presi.. Executive Vice President & COO May 26 Option 308.28 29,794 9,184,894 28,788 05/31/22
Lagarde Michel Executive Vice Presi.. Executive Vice President & COO May 26 Sell 550.77 29,794 16,409,641 15,758 05/31/22
Lagarde Michel Executive Vice Presi.. Executive Vice President & COO May 24 Option 237.32 22,198 5,268,029 20,806 05/25/22
Lagarde Michel Executive Vice Presi.. Executive Vice President & COO May 24 Sell 545.95 22,198 12,118,998 15,758 05/25/22
CASPER MARC N Chairman & CEO Chairman & CEO May 03 Sell 562.59 2,181 1,227,009 183,373 05/05/22
CASPER MARC N Chairman & CEO Chairman & CEO May 03 Option 129.77 20,000 2,595,400 193,373 05/05/22
Spar Debora L Director Director May 02 Sell 544.358 200 108,872 810 05/04/22
CASPER MARC N Chairman & CEO Chairman & CEO May 02 Option 129.77 10,000 1,297,700 193,373 05/04/22
CASPER MARC N Chairman & CEO Chairman & CEO May 02 Sell 544.98 10,000 5,449,800 183,373 05/04/22
MANZI JIM P Director Director Feb 14 Sell 563.95 1,500 845,925 16,252 02/15/22
CASPER MARC N Chairman & CEO Chairman & CEO Oct 28 Sell 484.63 20,000 9,692,600 211,594 10/28/20